Changes in serum histologic surrogate markers and procollagen III N-terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy; J.H. Koo et al.;Clin Biochem (2011), http://dx.doi.org/10.1016/j.clinbiochem.2011.09.023 (Clinical Biochemistry, 2011; SCI 학술지)

The Effects of Combined Treatment of Alendronate Plus Active or Plain Vitamin D on the Vitamin D Metabolism and Bone Turnover Markers in Patients with Osteoporosis; Koo J-H, et al.;Endocrinol Metab 25(4):305-309, December 2010, http://dx.doi.org/10.3803/EnM.2010.25.4.305

Entecavir Therapy for Patients with Hepatitis B Virus-related Decompensated Cirrhosis
In Sung Kim, Jun Il Mun, Jee Hoon Koo et al.;Korean J Gastroenterol Vol. 59 No. 3, 224-231

A Case of Long-Segment Barrett’s Esophagus with Mixed Connective Tissue Disease
Jun Il Mun, Dong Hoon Kim, Jee Hoon Koo et al.;The Korean Journal of Medicine: Vol. 82, No. 1, 2012,